MOULTRIE, GA — The Biograph Vision PET/CT represents one of the most significant advancements in medical imaging today, enhancing the accuracy and efficiency of diagnosing and monitoring a wide range of conditions, including cancer, cardiac disease, and neurological disorders. The system’s cutting-edge Optiso UDR detector technology delivers industry-leading time-of-flight performance, extraordinarily high resolution, and improved lesion detectability. With faster scan times, reduced dosage needs, and enhanced patient comfort, the Biograph Vision PET/CT sets a new standard for image clarity and diagnostic confidence.
This acquisition builds on Colquitt Regional’s expansive imaging capabilities, which already include a 3T MRI, multiple 128-slice CT scanners, advanced mammography, ultrasound services, and more. The addition of PET/CT imaging marks another milestone in expanding access to personalized, highly accurate diagnostic care.
“Our vision has always been to ensure that patients in our region have access to the most advanced diagnostic tools available,” said Colquitt Regional President and CEO Jim Matney. “The Siemens Biograph Vision PET/CT brings a remarkable level of precision and clarity that will directly benefit our patients. Whether for cancer care, cardiology, or neurology, this new technology allows our team to make earlier, more confident decisions—while keeping patients close to home.”
John Griffin, Chairman of the Colquitt County Hospital Authority, added, “This investment reflects Colquitt Regional’s unwavering commitment to continuous improvement and innovation. By bringing PET/CT imaging in-house, we are reducing barriers to timely diagnosis and ensuring patients have access to world-class technology right here in Moultrie. It’s another significant step in strengthening the comprehensive care available to our community.”
PET/CT imaging plays a vital role in modern medicine. In oncology, the advanced resolution and fast time-of-flight capabilities of the Biograph Vision help clinicians identify smaller lesions with greater accuracy, supporting more precise staging and treatment planning. In cardiology, the technology enhances myocardial blood-flow assessments and provides clearer, sharper imaging for conditions such as sarcoidosis. In neurology, the scanner’s ultra-high-resolution brain imaging offers improved assessment of structural and functional changes.
With this new addition, Colquitt Regional continues its focus on patient-centered, evidence-based care—supported by nationally competitive technology and delivered by a highly skilled imaging team. The health system also offers convenient patient-choice scheduling, ensuring timely access to imaging appointments.
“Providing cutting-edge technology is part of our commitment to exceptional care by exceptional people,” said Dr. Michael Brown, Colquitt Regional’s Chief Medical Officer and pulmonary/critical care physician. “This PET/CT system empowers our physicians and clinicians with information that leads to better outcomes—and most importantly, it gives our patients the confidence that they are receiving the best care possible.”
The Siemens Biograph Vision PET/CT is now available to patients five days a week, Monday through Friday. For more information, contact Colquitt Regional Marketing at 229-890-3552.
